Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN)

 
ACHN Technical Analysis
3
As on 31st Oct 2017 ACHN Share Price closed @ 4.02 and we RECOMMEND Sell for LONG-TERM with Stoploss of 4.21 & Sell for SHORT-TERM with Stoploss of 4.42 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ACHN Share Price

Open 4.09 Change Price %
High 4.18 1 Day -0.04 -0.99
Low 3.98 1 Week 0.00 0.00
Close 4.02 1 Month -0.57 -12.42
Volume 855091 1 Year -0.65 -13.92
52 Week High 5.66 | 52 Week Low 3.15
 
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
INTC 45.49 2.52%
 
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
 
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
 
 
ACHN
Daily Charts		 ACHN
Intraday Charts		 Whats New @
Bazaartrend		 ACHN
Free Analysis
 
ACHN Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE4.21
RESISTANCE4.13
SUPPORT3.91
SUPPORT3.83
SUPPORT0.00
SUPPORT0.00
 
ACHN Target for Month January
Share
4th UP TARGET6.29
3rd UP TARGET5.56
2nd UP TARGET5.11
1st UP TARGET4.66
1st DOWN TARGET3.38
2nd DOWN TARGET2.93
3rd DOWN TARGET2.48
4th DOWN TARGET1.75
 
ACHN Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
ACHN Target for Year 2021
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
ACHN Other Details
Segment EQ
Market Capital 720848960.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ACHN Address
ACHN
 300 George Street
New Haven, CT 06511
United States
Phone: 203-724-6000
Fax: 203-624-7003
 
ACHN Latest News
 
Your Comments and Response on Achillion Pharmaceuticals, Inc.
 
ACHN Business Profile
Achillion Pharmaceuticals, Inc., incorporated on August 17, 1998, is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the treatment of resistant bacterial infections. The Company focuses on the development of four drug candidates for the treatment of HCV: ACH-1625, a NS3 protease inhibitor for the treatment of HCV, which is being tested in a phase IIa clinical trial, ACH-2684, a NS3 protease inhibitor for the treatment of HCV, which is being tested in a phase I clinical trial; ACH-2928, a NS5A inhibitor for the treatment of HCV, which is being tested in a phase I clinical trial, and ACH-3102, a NS5A inhibitor for the treatment of HCV, which is being prepared for investigational new drug (IND), filing and initiation of a phase I clinical trial.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service